A research study Looking into blood levels of the medicine NNC0519-0130 in the body of participants with normal or reduced kidney function
NN9541-4923
Phase 1 other active
Quick answer
A research study Looking into blood levels of the medicine NNC0519-0130 in the body of participants with normal or reduced kidney function for Type 2 Diabetes Mellitus is a Phase 1 program (other) at Novo Nordisk A/S with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Novo Nordisk A/S
- Indication
- Type 2 Diabetes Mellitus
- Phase
- Phase 1
- Modality
- other
- Status
- active